GlassScriptPhysician profile
Thomas Henry Douglas
NPI 1336213883
$4,605.11
in general payments reported to CMS, 2019-2025
23 companies · $17.68 in 2025
The $17.68 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,156 · 2020: $2,087 · 2021: $633 · 2022: $388 · 2023: $29.78 · 2024: $294 · 2025: $17.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $341.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $1,788.00 | 2020 | |
| Teleflex LLC | $577.65 | 2021-2022 | |
| C. R. Bard, INC. & Subsidiaries | $424.89 | 2019-2025 | Bard Urinary Drainage Bag |
| Becton, Dickinson and Company | $385.00 | 2019 | |
| Boston Scientific Corporation | $256.07 | 2019-2024 | Spaceoar Vue System - 10ml, Rezum Generator |
| Astellas Pharma US INC | $224.86 | 2019-2020 | |
| Neotract INC. | $207.39 | 2020 | |
| Dendreon Pharmaceuticals LLC | $202.70 | 2019-2024 | Provenge |
| Endo Pharmaceuticals INC. | $89.78 | 2019 | |
| Pfizer INC. | $53.69 | 2019-2020 | |
| Dornier Medtech America, INC | $53.58 | 2019 | |
| Amgen INC. | $50.00 | 2019 | |
| Ferring Pharmaceuticals INC. | $47.01 | 2019 | |
| Therapeuticsmd, INC. | $40.72 | 2019 | |
| Rochester Medical Corporation | $37.65 | 2019-2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $37.52 | 2019-2020 | |
| Axonics, INC. | $28.58 | 2024 | Bulkamid, Axonics |
| Urovant Sciences INC | $19.88 | 2022 | |
| Amag Pharmaceuticals, INC. | $18.14 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $18.13 | 2019 | |
| Janssen Biotech, INC. | $16.51 | 2019 | |
| Abbvie INC. | $13.81 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Douglas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.